Literature DB >> 3489451

Adoptive transfer of immunity against virulent Semliki Forest virus with immune spleen cells from mice infected with avirulent Semliki Forest virus.

C A Kraaijeveld, B J Benaissa-Trouw, M Harmsen, H Snippe.   

Abstract

This paper describes the minimal requirements to protect mice adoptively against challenge with virulent Semliki Forest virus (SFV). Early immune serum, from donor mice infected with an avirulent strain of SFV, contained mainly neutralizing IgM immunoglobulins. More of these antibodies (1.80 PND50 vs 0.06 PND50) were needed to protect recipient mice against intraperitoneal challenge (10 LD50 of SFV) than against subcutaneous challenge (7 LD50). Adoptive transfer experiments indicated that a minimum of 3 X 10(7) six-day immune spleen cells were also able to protect recipient mice against intraperitoneal challenge with 10 LD50 of SFV. Treatment of these donor cells with cytotoxic antisera and complement revealed both T- and B-lymphocytes were required for optimum adoptive immunity. Surviving recipients of either immune serum or immune spleen cells developed significantly less neutralizing antibodies than control mice. The lower antibody titres in protected mice might be related to either immune serum or immune spleen cell mediated restriction of virus replication; meaning a reduced antigenic stimulus in these mice compared to control mice.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3489451     DOI: 10.1007/BF01316730

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  14 in total

1.  The virulence of original and derived strains of Semliki forest virus for mice, guinea-pigs and rabbits.

Authors:  C J Bradish; K Allner; H B Maber
Journal:  J Gen Virol       Date:  1971-08       Impact factor: 3.891

2.  Cellular immunity against Semliki Forest virus in mice.

Authors:  C A Kraaijeveld; M Harmsen; B Khader Boutahar-Trouw
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

3.  Cells involved in the in vitro stimulation by DNP-carrier complexes of in vivo primed mouse spleen cells.

Authors:  H Snippe; R V van Eyk
Journal:  Immunology       Date:  1974-11       Impact factor: 7.397

4.  Investigations into yellow fever virus and other arboviruses in the northern regions of Kenya.

Authors:  B E Henderson; D Metselaar; G B Kirya; G L Timms
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

5.  Gamma interferon production and cytotoxicity of spleen cells from mice infected with Semliki Forest virus.

Authors:  M J Blackman; A G Morris
Journal:  J Gen Virol       Date:  1984-05       Impact factor: 3.891

6.  Delayed hypersensitivity in the mouse induced by hapten-carrier complexes.

Authors:  H Snippe; P J Willems; W G Graven; E Kamp
Journal:  Immunology       Date:  1975-05       Impact factor: 7.397

7.  Delayed-type hypersensitivity in mice after infection with avirulent Semliki Forest virus. Brief report.

Authors:  C A Kraaijeveld; J Jansen; B Benaissa-Trouw; H Snippe
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

8.  Identification of distinct antigenic determinants on Semliki Forest virus by using monoclonal antibodies with different antiviral activities.

Authors:  W A Boere; T Harmsen; J Vinjé; B J Benaissa-Trouw; C A Kraaijeveld; H Snippe
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

9.  Quantitative studies of the inflammatory process in fatal viral meningoencephalitis.

Authors:  P C Doherty
Journal:  Am J Pathol       Date:  1973-12       Impact factor: 4.307

10.  Specificity of the inflammatory response in viral encephalitis. I. Adoptive immunization of immunosuppressed mice infected with Sindbis virus.

Authors:  H F McFarland; D E Griffin; R T Johnson
Journal:  J Exp Med       Date:  1972-08-01       Impact factor: 14.307

View more
  3 in total

Review 1.  Insights into Antibody-Mediated Alphavirus Immunity and Vaccine Development Landscape.

Authors:  Anthony Torres-Ruesta; Rhonda Sin-Ling Chee; Lisa F P Ng
Journal:  Microorganisms       Date:  2021-04-22

2.  Identifying the Role of E2 Domains on Alphavirus Neutralization and Protective Immune Responses.

Authors:  James Weger-Lucarelli; Matthew T Aliota; Attapon Kamlangdee; Jorge E Osorio
Journal:  PLoS Negl Trop Dis       Date:  2015-10-16

3.  Development of a novel S. Typhi and Paratyphi A outer membrane vesicles based bivalent vaccine against enteric fever.

Authors:  Debaki R Howlader; Hemanta Koley; Ritam Sinha; Suhrid Maiti; Ushasi Bhaumik; Priyadarshini Mukherjee; Shanta Dutta
Journal:  PLoS One       Date:  2018-09-14       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.